Bristol Paediatric ECMC
Centre
Bristol Paediatric ECMC is located at the Bristol Royal Hospital for Children (BRHC) in the city centre. The hospital, a dedicated children’s hospital, was first opened on the 22/04/2001 and was the first purpose-built children's Hospital in the South West. Children with cancers up to age 16 years are treated...
Combinations Alliance EOI Calls - Biothera
Basic page
Biothera Expression of Interest Call: open until 16 February 2015 We are delighted to announce that an additional company has joined the Combinations Alliance. Biothera are the latest company to offer their novel agent to the ECMC Network through this initiative and we look forward to a successful collaboration with...
Combinations Alliance EOI Calls - Verastem
Basic page
Verastem Expression of Interest Call - open until 16th February 2015 We are delighted to announce that Verastem have joined the Combinations Alliance. Verastem are the fifth partner to offer their agents to the ECMC Network through this initiative and we look forward to a successful collaboration with them. In...
Combinations Alliance EOI Calls - MedImmune
Basic page
MedImmune Expression of Interest Call, 1st - 16th July, 2014 We are delighted to announce MedImmune would like to offer two compounds to the Combinations Alliance and the NIHR CRN: Cancer Alliance. The two compounds on offer are; • MEDI0639 anti-DLL4 mAb • MEDI3617 anti-ANG2 mAb Please refer to the...
Combinations Alliance EOI Calls - Astex
Basic page
Astex Expression of Interest Call - open till 30th May, 2014 We are delighted to announce that Astex Pharmaceuticals have joined the Combinations Alliance. Astex are the third pharma partner to offer their agents to the ECMC Network through this initiative and we look forward to a successful collaboration with...
Combinations Alliance EOI Calls - AstraZeneca
Basic page
AstraZeneca Expression of Interest Call - open until 25th June, 2014 We are delighted to announce our next Joint Expression of Interest (EOI) call with the ECMC Combinations Alliance, AstraZeneca and the NIHR CRN: Cancer Alliance. Webexes were held on 14th and 21st May respectively covering the 13 compounds on...
Combinations Alliance EOI Calls - Lilly
Basic page
Lilly Expression of Interest Call 8th Jan - 7th February, 2014 We are delighted to announce Lilly have joined the Combinations Alliance as our second partner. The compound on offer for this Expression of Interest call is Lilly's Hedgehog inhibitor, LY2940680. Please contact us for access to the non-confidential LY2940680...
JING: Training the next generation 2015
Resource
Training the next generation programme 2015 Chairs, speakers and faculty biographies 2015 Presentations ECMCs - where do we fit in? - Aoife Regan Key factors in trial design - Robert Brown Support for early career investigators - CRUK - Karen Noble Early phase combination studies and industry alliances - Jeff...
Cross-Centre Placements and Skill-Sharing Scheme
Basic page
The cross-centre training and skill-sharing scheme has been set-up in response to the aim identified in the 2012 ECMC Network Strategy for more centres to be conducting studies of the highest quality due to improved staff training. The Cross-Centre Placements and Skill-Sharing Scheme applications can be made year-round at any...